Sanara Medtech Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 10.9% | 10.1% | 10.2% | 10.0% | 9.2% | 8.6% | 10.8% | 7.5% | 9.4% | 9.2% | 9.0% | 7.0% | 8.7% | |
| 89.1% | 89.9% | 89.8% | 90.0% | 90.8% | 91.4% | 89.2% | 92.5% | 90.6% | 90.8% | 91.0% | 93.0% | 91.3% | |
| 6.2% | 3.7% | 5.1% | 4.9% | 6.3% | 9.2% | 4.8% | 4.9% | 3.9% | 7.4% | 2.7% | 4.1% | 4.5% | |
| 86.6% | 92.3% | 87.4% | 94.0% | 87.6% | 85.2% | 91.5% | 83.4% | 75.5% | 72.9% | 78.7% | 80.3% | 76.9% | |
| 94.7% | 91.2% | 98.1% | 104.3% | 99.7% | 92.9% | 85.7% | 92.6% | 79.3% | 80.3% | 81.4% | 86.6% | 82.0% | |
| -5.7% | -1.3% | -8.3% | -14.3% | -8.9% | -1.4% | 3.5% | -0.1% | 11.2% | 10.5% | 9.5% | 6.3% | 9.4% | |
| 1.2% | 1.6% | 1.4% | 3.2% | 4.3% | 4.9% | 5.6% | 6.9% | 6.9% | 6.7% | 6.5% | 6.4% | 6.6% | |
| -6.8% | -1.5% | -9.7% | -17.5% | -13.3% | -6.5% | -2.6% | -7.8% | 3.2% | -4.0% | 1.4% | -1.5% | -0.3% | |
| -0.2% | -2.0% | -0.2% | -0.1% | – | 0.1% | – | – | – | – | – | – | – | |
| -6.6% | -1.3% | -9.5% | -17.4% | -13.2% | -5.8% | -15.0% | -7.8% | -115.5% | -5.8% | 1.7% | -1.6% | -29.2% | |
| 0.6% | -6.1% | -2.3% | -8.9% | -1.1% | 4.6% | 7.8% | 3.4% | 12.4% | 5.1% | 10.0% | 7.2% | 8.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.